Brodsky & Smith Announces Current Investigations Involving Karuna Therapeutics, Carrols Restaurant Group, Ansys, HomeStreet - Plus Updates on Restaurant Brands and Bristol-Myers Squibb

Investors are urged to take note as Brodsky & Smith, the legal firm with a focus on shareholder rights, has disclosed ongoing investigations into several publicly traded companies. These investigations concern the potential violation of federal securities laws or other unlawful business practices. Among the companies being examined are Karuna Therapeutics, Inc. KRTX, Carrols Restaurant Group, Inc. TAST, Ansys, Inc. ANSS, and HomeStreet, Inc. HMST, as well as Restaurant Brands International Inc. QSR and Bristol-Myers Squibb BMY.

Investigation Details

The company inquiries range across different industries, highlighting broader concerns about corporate governance and ethical conduct. Karuna Therapeutics, a biopharmaceutical firm, has a mission to develop drugs for people with psychiatric and neurological disorders. HomeStreet, Inc., offers banking services across the western US, while Ansys, Inc. specializes in engineering simulation software. Restaurant Brands International runs well-known fast food chains, and Bristol-Myers Squibb is known for its contributions to the pharmaceutical sector.

Shareholder Information

Brodsky & Smith is reaching out to shareholders who may have been affected by the actions of these companies. They offer legal counsel and aim to protect investor rights through litigation or settlements. Shareholders who have invested in these companies and are concerned about their shares' performance are welcome to discuss potential legal actions with Jason Brodsky [email protected] or Marc Ackerman [email protected] at 855-576-4847.

Brodsky, Smith, Investigations